(Q38058380)

27 August 2017

Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment (English)

1 reference

27 August 2017

0 references

1 reference

1 reference

R van der Pas

1

1 reference

27 August 2017

F W G Leebeek

2

1 reference

27 August 2017

L J Hofland

3

1 reference

27 August 2017

W W de Herder

4

1 reference

27 August 2017

R A Feelders

5

1 reference

27 August 2017

language of work or name

1 reference

1 April 2013

1 reference

27 August 2017

Clinical Endocrinology

1 reference

27 August 2017

78

1 reference

27 August 2017

481-488

1 reference

27 August 2017

4

1 reference

Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature.

27 August 2017

1 reference

Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma.

21 January 2018

1 reference

Incidence and late prognosis of cushing's syndrome: a population-based study

21 January 2018

1 reference

21 January 2018

1 reference

Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure.

21 January 2018

1 reference

Neuropsychiatric disorders in Cushing's syndrome.

21 January 2018

1 reference

Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing's disease

21 January 2018

1 reference

Quality of life in patients with a pituitary adenoma

21 January 2018

1 reference

Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire.

21 January 2018

1 reference

Quality of life in patients after long-term biochemical cure of Cushing's disease.

21 January 2018

1 reference

Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement

21 January 2018

1 reference

Medical therapy of Cushing's disease

21 January 2018

1 reference

Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort study.

21 January 2018

1 reference

Hypercoagulable state in Cushing's syndrome: a systematic review

21 January 2018

1 reference

Venous thromboembolism in patients with Cushing's syndrome: need of a careful investigation of the prothrombotic risk profile.

21 January 2018

1 reference

Cerebral sinus thrombosis in a patient with Cushing's syndrome.

21 January 2018

1 reference

Coagulopathy in Cushing's syndrome.

21 January 2018

1 reference

Complications in a contemporary series of patients who underwent transsphenoidal surgery for Cushing's disease

21 January 2018

1 reference

Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission

21 January 2018

1 reference

National trends, complications, and outcomes following transsphenoidal surgery for Cushing's disease from 1993 to 2002.

21 January 2018

1 reference

Thrombosis and malignancy: a case-based review

21 January 2018

1 reference

The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy.

21 January 2018

1 reference

Hyperhomocysteinemia in patients with Cushing's syndrome

21 January 2018

1 reference

Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers.

21 January 2018

1 reference

Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels.

21 January 2018

1 reference

Acute phase mediators modulate thrombin-activable fibrinolysis inhibitor (TAFI) gene expression in HepG2 cells

21 January 2018

1 reference

Type 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoter

21 January 2018

1 reference

Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue

21 January 2018

1 reference

Effect of high-dose dexamethasone on endothelial haemostatic gene expression and neutrophil adhesion.

21 January 2018

1 reference

Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers.

21 January 2018

1 reference

Hypofibrinolysis is a risk factor for arterial thrombosis at young age.

21 January 2018

1 reference

Binding of von Willebrand factor to glycoproteins Ib and IIb/IIIa complex: affinity is related to multimeric size

21 January 2018

1 reference

Obesity, haemostasis and the fibrinolytic system

21 January 2018

1 reference

Disorders of coagulation and hemostasis in abdominal obesity: emerging role of fatty liver

21 January 2018

1 reference

Obesity as a risk factor in venous thromboembolism

21 January 2018

1 reference

Thrombosis and cancer: 40 years of research

21 January 2018

1 reference

Hypercoagulability in cancer

21 January 2018

1 reference

Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease.

21 January 2018

1 reference

Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

21 January 2018

1 reference

Incidence and management of complications of transsphenoidal operation for pituitary adenomas.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CEN.12094

1 reference

27 August 2017

1 reference